Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 85.60
+1.80 (2.15%)
Oct 15, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 146.61 billion as of October 15, 2025. Its market cap has increased by 111.00% in one year.
Market Cap
146.61B
Enterprise Value
139.86B
Revenue
12.52B
Ranking
n/a
PE Ratio
115.79
Stock Price
85.60
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 146.61B, an increase of 690.83%. That is a compound annual growth rate of 34.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 143.53B | 139.39% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | 115.10B | 243.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.25B |
| Hansoh Pharmaceutical Group Company | 219.27B |
| JD Health International | 200.41B |
| WuXi Biologics | 153.85B |
| Sino Biopharmaceutical | 139.44B |
| Akeso | 117.91B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.93B |
| CSPC Pharmaceutical Group | 108.96B |